MedPath
NMPA Approval

Bortezomib for Injection

国药准字H20253276

January 24, 2025

Drug Information

注射用硼替佐米

注射剂

3.5mg

化学药品

January 24, 2025

Company Information

Applicant Company

武汉东湖新技术开发区高新大道858号生物医药园

Manufacturing Company

湖北省武汉东湖新技术开发区高新大道858号生物医药园A1-1

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用硼替佐米 - NMPA 批准文号 | MedPath